Connect with us

Crypto World

MiniMed (MMED) IPO Falls Flat as Medtronic (MDT) Spinoff Debuts Below Price

Published

on

MMED Stock Card

TLDR

  • MiniMed (MMED) started trading at $19.05 on Friday, March 6, falling 4.8% below the $20 IPO offering price in its Nasdaq launch.
  • The diabetes technology firm generated $560 million through the sale of 28 million shares — significantly lower than the anticipated $25–$28 pricing range.
  • The opening price established MiniMed’s market capitalization at $5.35 billion.
  • Medtronic (MDT) continues to control approximately 90% ownership following the initial public offering.
  • Market conditions were challenging on debut day, with the VIX surging to its highest level in four months after disappointing employment data.

The highly anticipated public market entrance of MiniMed fell short of expectations on Friday. Shares of the diabetes device manufacturer began trading at $19.05 on Nasdaq — representing a 4.8% decline from the $20 offering price — establishing a company valuation of $5.35 billion.


MMED Stock Card
MiniMed Group, Inc. Common Stock, MMED

Market sentiment proved challenging across the board. The CBOE Volatility Index climbed to its highest point in four months, fueled by disappointing employment figures that rattled investor confidence. These conditions created far from ideal circumstances for a debut listing.

The transaction generated $560 million in proceeds through the placement of 28 million shares. This represented a significant reduction from initial expectations — the marketed pricing range stood at $25 to $28 per share, forcing MiniMed to accept a substantial discount to complete the transaction.

Market observers had expressed skepticism about whether the original valuation made sense, and the final pricing appears to validate those concerns.

A Tough Market for New Listings

The IPO environment has faced significant headwinds in recent weeks. Anxieties surrounding artificial intelligence disruption and global political instability have reduced enthusiasm for new public offerings, constraining activity throughout the market.

Advertisement

MiniMed’s challenging debut reflects this broader trend. Even established brands are struggling to achieve premium pricing in the current environment.

Medtronic (MDT) executed the separation to generate funds and create an independent diabetes-focused entity. Following completion of the IPO, Medtronic maintains approximately 90.03% ownership of MiniMed — a figure that would drop to 88.70% should underwriters fully exercise their 30-day option to acquire an additional 4.2 million shares.

The transaction is expected to finalize on March 9, 2026.

MiniMed intends to deploy the capital raised for general operational needs, settling intercompany obligations owed to Medtronic, and covering expenses related to asset transfers completed during the separation.

Advertisement

Back to Growth After Regulatory Headwinds

The organization previously encountered regulatory challenges regarding quality control systems and cybersecurity vulnerabilities associated with certain products. Those issues have been resolved, and the company has demonstrated renewed growth momentum in recent reporting periods.

MiniMed operates in a competitive landscape alongside Beta Bionics, Dexcom (DXCM), Insulet (PODD), and Tandem Diabetes Care (TNDM) within the diabetes technology sector.

The company’s portfolio encompasses insulin delivery pumps, continuous glucose monitoring platforms, and sensor technology designed for individuals managing both type 1 and type 2 diabetes.

Medtronic (MDT) finished Thursday’s session lower at $93.01 before the spinoff company’s market debut.

Advertisement

Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Crypto World

Community Banks, Crypto Industry ‘Are Allies’ In CLARITY Act Clash: Exec

Published

on

Cryptocurrencies, Banks, Adoption, United States

A crypto executive has pushed back against claims by the president of a community banking association that any compromise between the banking sector and the crypto industry on the US CLARITY Act would be a mistake.

“If community banks and crypto can’t find a way to work together, we already know who the winners are. It’s not the community banks. It’s not consumers. It’s not the crypto industry,” Zero Knowledge Consulting founder Austin Campbell said in an X post on Friday.

“It is the big banks,” Campbell said.

“There is a very straight line between the value community banks bring,” he said, explaining that they face technological and regulatory issues that can be solved by stablecoins.

Advertisement

The major banks “have tricked both sides”

“These are not enemies,” Campbell said of stablecoin-yield providers and community banks, adding that “they are allies.”

“The big banks and the bank lobbies they fund have tricked both sides into fighting each other so that the ultimate winner is Jamie Dimon’s bonus,” he said. 

Cryptocurrencies, Banks, Adoption, United States
Source: Patrick Witt

Campbell’s comments came in response to Independent Bankers Association of Texas president Christopher Williston, who said that making concessions in the CLARITY Act debate would risk harming local lending and economic production.

“It’s simply impossible to roll over in the fight for liquidity that powers the economies of the places we call home,” he said.

Banking lobby groups have argued that if the CLARITY Act passes in its current form, stablecoins could siphon deposits from the banking system. Major US bank Standard Chartered recently estimated in a research note that increasing stablecoin adoption could lead to US bank deposits decreasing “by one-third of stablecoin market cap.”

Advertisement

The debate has also drawn comments from the Trump family this week.

Eric Trump, the son of US President Donald Trump, said in a X post on Thursday that large banks are not acting in the best interests of US citizens. “Big Banks (think JPMorgan Chase, Bank of America, Wells Fargo, etc.) are lobbying overtime to block Americans from getting higher yields on their savings.”

Donald Trump urges the bill to pass “ASAP”

US President Donald Trump also criticized banks for stalling the Senate’s crypto market-structure bill amid ongoing disagreements over stablecoin yield payments.

Advertisement

Related: Revolut makes second attempt at US bank charter, names new CEO for US business

“The U.S. needs to get Market Structure done, ASAP,” Trump said. “The Banks are hitting record profits, and we are not going to allow them to undermine our powerful Crypto Agenda,” he added.

Magazine: The debate over Bitcoin’s four-year cycle is over: Benjamin Cowen